IRE1α knockdown, but not inhibition of its enzymatic function, impaired cell cycle progression and tumor growth by activating p53/p21 and increasing DNA damage, emphasizing a critical non-enzymatic function of IRE1α in cancer biology [60]. Here, TP53 is linked to cancer.